the present invention, the following structural formula ( ) of triethyl-acetyl-3 - hydroxy-phenyl-adenosine and preparation and The drug combination has been described with respect to the use of water. Specifically, in one of the new compounds other 2 , 3, 5-acetyl-tree -O- -N 6 - (3- hydroxy-phenyl) adenosine was released. As a method of manufacturing the above-mentioned compound as a starting material was obtained by inosine after the acetylation, and 3-substituted bangeung the chloride displacement reaction of aniline hydrochloride with thionyl chloride in the acetic anhydride. Water was also disclosed drug combinations containing triethyl acetyl-3-hydroxy-phenyl-adenosine. The above-mentioned combination drug formulations are water tablets, capsules, pills, injections, sustained release formulations, the release control agent or other particulate dosage system and the like. Compounds preventive and / or therapeutic activity against hyperlipidemia of the present invention has the effect of activating blood if there is clear and the side effects were less dominant in the body such as metabolism is slow.본 발명에서는 구조식(Ⅰ)의 트리에틸아세틸-3-히드록실페닐아데노신과 제조방법 및 그 약물조합물의 용도에 대하여 설명하였다. 구체적으로 말하면 한가지 새로운 화합물인 2,3,5-트리-O-아세틸-N6-(3-히드록실페닐)아데노신을 공개하였다. 상술한 화합물의 제조방법으로는 이노신을 원료로 하여 아세트산 무수물의 아세틸화, 염화티오닐의 염화치환반응 및 3-염산아닐린의 치환 방응을 거쳐 얻었다. 또한 트리에틸아세틸-3-히드록실페닐아데노신을 함유한 약물조합물도 공개하였다. 상술한 약물조합물의 제제에는 정제, 캡슐제, 환제, 주사제, 지효성제제, 방출조절제 혹은 기타 미립자투약계 등이 있다. 본 발명의 화합물은 고지질혈증에 대하여 예방과/혹은 치료 작용이 있으며 혈지를 활성화시키는 작용이 선명하고 부작용이 작으며 체내에서의 대사가 느린 등 우점이 있다.
